Schedule 13D ownership disclosure

CONNECT BIOPHARMA HLDGS LTD

Security class unavailable · CUSIP: 207523101

Event date: 2024-02-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-028214
Form type
SC 13D/A
Filer
Connect Biopharma Holdings Ltd
CIK
CIK 1835268
Filed
Feb 27, 2024
Reporting period
Feb 23, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub